US20060094744A1 - Pharmaceutical dosage forms of stable amorphous rapamycin like
compounds - Google Patents US20060094744A1 - Pharmaceutical dosage forms of stable …

US8703204B2 - Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and
anon-ionizable polymer - Google Patents US8703204B2 - Nanoparticles comprising a …

USPC.................................................. 424/464 489 (7) ABSTRACT See application file for
complete search history. A modified release composition comprising tacrolimus releases …

An extended release oral dosage form comprising as active Substance tacrolimus or a
pharmaceutically active analogue thereof for a once daily immunosuppressive treatment of a …

US8974827B2 - Nanoparticles comprising a non-ionizable cellulosic polymer and an
amphiphilic non-ionizable block copolymer - Google Patents US8974827B2 - Nanoparticles …

US7994214B2 - Solid dispersions comprising tacrolimus - Google Patents US7994214B2 -
Solid dispersions comprising tacrolimus - Google Patents Solid dispersions comprising …

An extended release oral dosage form comprising as active substance tacrolimus or a
pharmaceutically active analogue thereof for a once daily immunosuppressive treatment of a …

Jun. 23, 2011, now Pat. No. 8,623,411, which is a FOREIGN PATENT DOCUMENTS
continuation of application No. 10/569,862, filed as EP O184162 A2 6, 1986 application No …

De Boer, AH, et al., Characterization of inhalation aerosols: a criti (51) Int. Cl. cal evaluation
of cascade impactor analysis and laser diffraction A6 IK 9/14(2006.01) technique. Int. J …

The present invention relates to the carrier of the solid dispersion of tacrolimus, which is
prepared by using the solid surfactant having a property of HLB value higher than or equal …